A safety analysis of oral prednisone as a pretreatment for rituximab in rheumatoid arthritis

Clinical Rheumatology

Volumn 31, Issue 11, 2012, Pages 1605-1610

  Carter, J D ^a,c   Zarabadi, S A ^a   Ricca, L R ^a   McNeil, A ^b   Valeriano Marcet, J ^a   Vasey, F B ^a   Sebba, A I ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NONE

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Infusion reactions; Methylprednisolone; Prednisone; Rheumatoid arthritis; Rituximab

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB;

ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHENIA; BRONCHOSPASM; CHILL; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; DIZZINESS; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; HEADACHE; HOT FLUSH; HUMAN; HYPERTENSION; HYPOTENSION; INFUSION RELATED REACTION; MALE; MYALGIA; NAUSEA; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RASH; RHEUMATOID ARTHRITIS; RHINITIS; RIGOR; THROAT IRRITATION; URTICARIA; VOMITING; WHEEZING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SAFETY; PREDNISONE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872174559     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-2059-4     Document Type: Article

References (12)

1. Edwards J, Szczepanski L, Szechinski J, Filiowicz-Sosnowska A, Emery P, Close D, Stevens R, Shaw T (2004) Efficacy B-celltargeted therapy with Rituximab in patients with rheumatoid arthritis. N Engl J Med 350:2572-2581
2. Emery P, Fleischmann R, Filiowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, Racewicz J, van Vollenhoven R, Li N, Agarwal S, Hessey E, Shaw T (2006) The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIb randomized, double-blind, placebocontrolled, dose-ranging trial. Arthritis Rheum 54(5):1390-1400
3. Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC et al (2006) Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54(9):2793-2806
4. Rituxan [package insert] (2011). Biogen Idec, Inc. and Genentech, Inc., South San Francisco; April 2011.
5. Mager DE, Lin SX, Blum RA, Lates CD, Jusko WJ (2003) Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics. J Clin Pharm 43:1216-1227
6. Jonsson S, Kjartansson G, Gislason D, Helgason H (1988) Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline. Chest 94(4):723-726
7. Lee KM, Lin YZ, Huang FY (2001) Steroid-induced acute psychosis in a child with asthma: report of one case. Acta Paediatr Taiwan 42(3):169-171
8. Klein-Gitelman MS, Pachman LM (1998) Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol 25(10):1995-2002
9. Chrousos GA, Kattah JC, Beck RW, Cleary PA (1993) Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. JAMA 269(16):2110-2112
10. Shipley ME, Bacon PA, Berry H, Hazleman BL, Sturrock RD, Swinson DR, Williams IA (1988) Pulsed methylprednisolone in active early rheumatoid disease: a dose-ranging study. Br J Rheumatol 27(3):211-214
11. Klareskog L, Gaubitz M, Rodriguez-Valverde V, Malaise M, Dougados M, Wajdula J (2006) A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs. Ann Rheum Dis 65(12):1578-1584
12. Ruiz Garcia V, Jobanputra P, Burls A, Cabello JB, Gálvez Muñoz JG, Saiz Cuenca ES, Fry-Smith A (2011) Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. Cochrane Database Syst Rev 16(2):CD007649